American Century Companies Inc. Lowers Stock Position in Exponent, Inc. $EXPO

American Century Companies Inc. reduced its stake in Exponent, Inc. (NASDAQ:EXPOFree Report) by 6.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,286 shares of the business services provider’s stock after selling 1,783 shares during the quarter. American Century Companies Inc. owned about 0.05% of Exponent worth $2,131,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Whipplewood Advisors LLC raised its stake in Exponent by 5,333.3% in the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider’s stock valued at $26,000 after purchasing an additional 320 shares in the last quarter. UMB Bank n.a. raised its stake in Exponent by 859.1% in the first quarter. UMB Bank n.a. now owns 633 shares of the business services provider’s stock valued at $51,000 after purchasing an additional 567 shares in the last quarter. Bessemer Group Inc. raised its stake in Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock valued at $55,000 after purchasing an additional 346 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its stake in Exponent by 8,092.9% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider’s stock valued at $93,000 after purchasing an additional 1,133 shares in the last quarter. Finally, LRI Investments LLC raised its stake in Exponent by 30.4% in the fourth quarter. LRI Investments LLC now owns 1,460 shares of the business services provider’s stock valued at $130,000 after purchasing an additional 340 shares in the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.

Exponent Price Performance

Shares of EXPO opened at $71.38 on Tuesday. The firm’s 50 day simple moving average is $72.52 and its 200 day simple moving average is $77.11. The company has a market capitalization of $3.60 billion, a P/E ratio of 35.69 and a beta of 0.94. Exponent, Inc. has a 1-year low of $63.81 and a 1-year high of $115.75.

Exponent (NASDAQ:EXPOGet Free Report) last announced its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.04. The business had revenue of $132.87 million for the quarter, compared to the consensus estimate of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. Exponent’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period last year, the firm posted $0.57 earnings per share. On average, equities analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 19th. Shareholders of record on Friday, September 5th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, September 5th. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. Exponent’s dividend payout ratio (DPR) is 60.00%.

Insider Activity at Exponent

In other Exponent news, VP Joseph Sala sold 1,595 shares of Exponent stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total transaction of $112,670.80. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Catherine Corrigan sold 4,896 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $71.09, for a total transaction of $348,056.64. Following the completion of the transaction, the chief executive officer owned 81,342 shares in the company, valued at $5,782,602.78. This represents a 5.68% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.